Anna Dolnik

Venetoclax resistance and acquired <i>BCL2</i> mutations in chronic lymphocytic leukemia

Eugen Tausch, William Close, Anna Dolnik et al. · Haematologica · 2019 · 203 citations · Full text

Medicine, Genetics, Oncology +11

Clonal evolution of acute myeloid leukemia with <i>FLT3</i>-ITD mutation under treatment with midostaurin

Laura K. Schmalbrock, Anna Dolnik, Sibylle Cocciardi et al. · Blood · 2021 · 158 citations · Full text

Medicine, Hematology, Oncology +14

Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing

Anna Dolnik, Julia C. Engelmann, Maren Scharfenberger‐Schmeer et al. · Blood · 2012 · 151 citations · Full text

Medicine, Genetics, Molecular Genetics +17

Cytogenetics and gene mutations influence survival in older patients with acute myeloid leukemia treated with azacitidine or conventional care

Hartmut Döhner, Anna Dolnik, Lin Tang et al. · Leukemia · 2018 · 134 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +15

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax

Eugen Tausch, Christof Schneider, Sandra Robrecht et al. · Blood · 2020 · 127 citations · Full text

Life Sciences, Genetics, Molecular Genetics +14